Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1180555.029Peak area normalizedmale diabetic Neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1245697.33Peak area normalizedfemale diabetic Neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1248975.196Peak area normalizedmale pre-diabetic Neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1254597.343Peak area normalizedfemale diabetic no neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1320330.373Peak area normalizedfemale diabetic Neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1333167.856Peak area normalizedfemale normoglycemic no neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1372885.959Peak area normalizedfemale diabetic no neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1485883.951Peak area normalizedfemale diabetic Neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1510822.196Peak area normalizedfemale normoglycemic Neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1652304.306Peak area normalizedfemale diabetic no neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1776784.045Peak area normalizedmale pre-diabetic no neuropathy
C18 NEGATIVE ION MODEFFA(20:0)1905895.824Peak area normalizedmale diabetic no neuropathy
C18 NEGATIVE ION MODEFFA(20:0)2217979.939Peak area normalizedfemale diabetic no neuropathy
C18 NEGATIVE ION MODEFFA(20:0)2937285.779Peak area normalizedfemale diabetic Neuropathy

Return to search page
  logo